Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine
Authors
Keywords
-
Journal
ACTA NEUROPSYCHIATRICA
Volume 27, Issue 03, Pages 159-167
Publisher
Cambridge University Press (CUP)
Online
2015-02-04
DOI
10.1017/neu.2015.1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting of NMDA receptors in new treatments for schizophrenia
- (2014) Kenji Hashimoto EXPERT OPINION ON THERAPEUTIC TARGETS
- Abnormalities of the glutamine–glutamate–GABA cycle in the schizophrenia brain
- (2014) Kenji Hashimoto SCHIZOPHRENIA RESEARCH
- D-Amino Acid Oxidase Inhibitors as a Novel Class of Drugs for Schizophrenia Therapy
- (2013) Silvia Sacchi et al. CURRENT PHARMACEUTICAL DESIGN
- Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
- (2013) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Up-Regulation of Neurotrophic Factors by Cinnamon and its Metabolite Sodium Benzoate: Therapeutic Implications for Neurodegenerative Disorders
- (2013) Arundhati Jana et al. Journal of Neuroimmune Pharmacology
- Effects of TrkB agonist 7,8-dihydroxyflavone on sensory gating deficits in mice after administration of methamphetamine
- (2013) Qian Ren et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- 7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine
- (2013) Qian Ren et al. PSYCHOPHARMACOLOGY
- Inflammation and Schizophrenia
- (2013) B. Kirkpatrick et al. SCHIZOPHRENIA BULLETIN
- A pilot double-blind comparison of d-serine and high-dose olanzapine in treatment-resistant patients with schizophrenia
- (2013) Marina Ermilov et al. SCHIZOPHRENIA RESEARCH
- Add-on Treatment of Benzoate for Schizophrenia
- (2013) Hsien-Yuan Lane et al. JAMA Psychiatry
- A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
- (2012) Mark Weiser et al. JOURNAL OF CLINICAL PSYCHIATRY
- Plasma levels of D-serine in Brazilian individuals with schizophrenia
- (2012) Marilia A. Calcia et al. SCHIZOPHRENIA RESEARCH
- Effects of the Antioxidant Sulforaphane on Hyperlocomotion and Prepulse Inhibition Deficits in Mice after Phencyclidine Administration
- (2012) Yumi Shirai et al. Clinical Psychopharmacology and Neuroscience
- Recent Advances in the Discovery of D-Amino Acid Oxidase Inhibitors and Their Therapeutic Utility in Schizophrenia
- (2011) Dana V. Ferraris et al. CURRENT PHARMACEUTICAL DESIGN
- Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Neuroprotective Parkinson Disease Protein DJ-1 in Astrocytes and Neurons
- (2011) Saurabh Khasnavis et al. Journal of Neuroimmune Pharmacology
- Levels of d-serine in the brain and peripheral organs of serine racemase (Srr) knock-out mice
- (2011) Mao Horio et al. NEUROCHEMISTRY INTERNATIONAL
- Contributions of the d-serine pathway to schizophrenia
- (2011) Viviane Labrie et al. NEUROPHARMACOLOGY
- Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine
- (2011) Hongxian Chen et al. PSYCHOPHARMACOLOGY
- Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia
- (2010) Daisuke Matsuzawa et al. ANTIOXIDANTS & REDOX SIGNALING
- Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View
- (2010) Jeffrey K. Yao et al. ANTIOXIDANTS & REDOX SIGNALING
- Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
- (2010) Guochuan Tsai et al. CURRENT PHARMACEUTICAL DESIGN
- High dose D-serine in the treatment of schizophrenia
- (2010) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine
- (2009) Kenji Hashimoto et al. BIOLOGICAL PSYCHIATRY
- Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: A possible role of α1-adrenoceptors
- (2009) Yuko Tanibuchi et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Reduces Microglial and Astroglial Inflammatory Responses
- (2009) S. Brahmachari et al. JOURNAL OF IMMUNOLOGY
- Comments on ‘The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia’
- (2009) Kenji Hashimoto JOURNAL OF PSYCHOPHARMACOLOGY
- Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: Role of serotonin 5-HT1A receptors
- (2008) Hiroko Hagiwara et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Synthesis and Biological Evaluation ofd-Amino Acid Oxidase Inhibitors
- (2008) Dana Ferraris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Microglial activation in schizophrenia and minocycline treatment
- (2008) Kenji Hashimoto PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia
- (2008) Caroline Madeira et al. SCHIZOPHRENIA RESEARCH
- Phencyclidine-Induced Cognitive Deficits in Mice Are Improved by Subsequent Subchronic Administration of the Novel Selective α7 Nicotinic Receptor Agonist SSR180711
- (2007) Kenji Hashimoto et al. BIOLOGICAL PSYCHIATRY
- Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and d-serine
- (2007) Kenji Hashimoto et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline
- (2007) Yuko Fujita et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started